Penn Medicine offers a full range of diagnostic tools and individualized treatment plans for those afflicted by liver cancer.
Liver cancer is a cancer that forms in the lining of the liver and can be categorized as primary, cancer that forms in the tissues of the liver, or secondary, cancer that spreads to the liver from another part of the body.
At Penn Medicine's Abramson Cancer Center, patients with liver cancer, also known as hepatic cancer or hepatocellular carcinoma (HCC), receive their care from a multidisciplinary team of nationally recognized experts in the diagnosis, treatment and research of gastrointestinal cancer.
Our Gastrointestinal Cancer Program is the first of its kind. Our close collaboration with our transplant program provides access to comprehensive medical and surgical care for patients who require a liver transplant. The Penn Transplant Institute has performed more than 1,500 liver transplants.
Penn Medicine's multidisciplinary approach to cancer diagnosis and treatment provides better outcomes and gives patients access to the most advanced treatment, surgical techniques and clinical trials.
To connect with a cancer nurse at Penn Medicine, please call 800-789-7366 (PENN).
Oncology Navigators
Every step of liver cancer treatment, from a cancer diagnosis and treatment, to forming a survivorship plan, comes with different needs and issues that should be addressed.
Oncology navigators are committed to making sure every patient experience is as comfortable as possible. They are experts in navigating complex health care situations and serve as a consistent point of contact and a reliable source for advice, support and direction for patients and families.